跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NR-NO2
首页
药物
NR-NO2
NR-NO2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES
WO 02060896 A1
申请人: PFIZER PROD INC
优先权: 2001
CN
US
WO
4 件公开
5-(1H-indol-3-yl)-oxazole, -oxadiazole and -furan derivatives as enhancers of sperm motility
US 12616193 B2
申请人: SPERMATECH AS
优先权: 2020
CN
EP
US
3 件公开
Photoactivable nitrogen bases
US 7538104 B2
申请人: CIBA SC HOLDING AG
优先权: 2001
US
2 件公开
Compounds and their therapeutic use
US 2003199508 A1
申请人: RUZAFA SANTIAGO CONDE
优先权: 2001
US
2 件公开
Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
US 6268391 B1
申请人: GLAXO WELLCOME INC
优先权: 1998
US
Oxazolidinones and their use as antibacterial agents
EP 1029854 A1
申请人: BAYER AG
优先权: 1999
EP
Composition containing at least a bicyclic aromatic compound and at least a lipopholic sunscreen, and its uses
EP 1050296 A1
申请人: OREAL
优先权: 1999
EP
Quinophthalone-derivative based crystallization modifiers
US 6849116 B2
申请人: BASF AG
优先权: 2000
US
Process for the preparation of carboxylic acid amides by oxidation of aldehydes in the presence of amines
EP 1179525 A1
申请人: DEGUSSA
优先权: 2000
EP
Compounds and methods for modulating cxcr3 function
US 6559160 B1
申请人: CHEMOCENTRYX INC
优先权: 2000
US
第 1 / 7 页
上一页
下一页
药物
反馈